ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
AstraZeneca
AstraZeneca
Mayo Clinic
Mayo Clinic
Kivu Bioscience Inc.
MediLink Therapeutics (Suzhou) Co., Ltd.
University of Chicago
Bayer
National Cancer Institute (NCI)
Convalife (Shanghai) Co., Ltd.
Eastern Cooperative Oncology Group
Neonc Technologies, Inc.
ViroMissile, Inc.
Rutgers, The State University of New Jersey
Arcus Biosciences, Inc.
Terremoto Biosciences Inc.
Kaiser Permanente
Sichuan Enray Pharmaceutical Sciences Company
Qurient Co., Ltd.
AstraZeneca
AstraZeneca
Tizona Therapeutics, Inc
National Institutes of Health Clinical Center (CC)
Genentech, Inc.
Normunity AccelCo, Inc.
Ohio State University Comprehensive Cancer Center
Eli Lilly and Company
Jonsson Comprehensive Cancer Center
University of Colorado, Denver
MacroGenics
SystImmune Inc.
Pheon Therapeutics
Daiichi Sankyo
Eli Lilly and Company
Adela, Inc
Orano Med LLC
Radiopharm Theranostics, Ltd
ImmunityBio, Inc.
Eli Lilly and Company
Ocellaris Pharma, Inc.
Medical College of Wisconsin
Innate Pharma
Brigham and Women's Hospital
National Institutes of Health Clinical Center (CC)
City of Hope Medical Center
Instituto do Cancer do Estado de São Paulo
Mayo Clinic
University of Pittsburgh
Tanabe Pharma America, Inc.
City of Hope Medical Center
University of Southern California